SPSB2 (splA/ryanodine receptor domain and SOCS box containing 2)

2009-10-01  

Identity

HGNC
LOCATION
12p13.31
LOCUSID
ALIAS
GRCC9,SSB2

Other Information

Locus ID:

NCBI: 84727
MIM: 611658
HGNC: 29522
Ensembl: ENSG00000111671

Variants:

dbSNP: 84727
ClinVar: 84727
TCGA: ENSG00000111671
COSMIC: SPSB2

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000111671ENST00000432205E5RIC2
ENSG00000111671ENST00000519357Q99619
ENSG00000111671ENST00000523102Q99619
ENSG00000111671ENST00000524270Q99619

Expression (GTEx)

0
5
10
15
20

Pathways

PathwaySourceExternal ID
Immune SystemREACTOMER-HSA-168256
Adaptive Immune SystemREACTOMER-HSA-1280218
Class I MHC mediated antigen processing & presentationREACTOMER-HSA-983169
Antigen processing: Ubiquitination & Proteasome degradationREACTOMER-HSA-983168

Protein levels (Protein atlas)

Not detected
Low
Medium
High

PharmGKB

Entity IDNameTypeEvidenceAssociationPKPDPMIDs
PA447197Attention Deficit Disorder with HyperactivityDiseaseClinicalAnnotation, VariantAnnotationassociatedPD29382897
PA450464methylphenidateChemicalClinicalAnnotation, VariantAnnotationassociatedPD29382897

References

Pubmed IDYearTitleCitations
338622002021Structural basis for the regulation of inducible nitric oxide synthase by the SPRY domain-containing SOCS box protein SPSB2, an E3 ubiquitin ligase.1
338622002021Structural basis for the regulation of inducible nitric oxide synthase by the SPRY domain-containing SOCS box protein SPSB2, an E3 ubiquitin ligase.1
312046872019Crystal structure of the SPRY domain of human SPSB2 in the apo state.1
313441332019SPSB2 inhibits hepatitis C virus replication by targeting NS5A for ubiquitination and degradation.4
312046872019Crystal structure of the SPRY domain of human SPSB2 in the apo state.1
313441332019SPSB2 inhibits hepatitis C virus replication by targeting NS5A for ubiquitination and degradation.4
285495822017Crystal structure of SPSB2 in complex with a rational designed RGD-containing cyclic peptide inhibitor of SPSB2-iNOS interaction.4
285495822017Crystal structure of SPSB2 in complex with a rational designed RGD-containing cyclic peptide inhibitor of SPSB2-iNOS interaction.4
196090182009Transcriptomic profile of two canine mammary cancer cell lines with different proliferative and anti-apoptotic potential.16
196090182009Transcriptomic profile of two canine mammary cancer cell lines with different proliferative and anti-apoptotic potential.16

Citation

Dessen P

SPSB2 (splA/ryanodine receptor domain and SOCS box containing 2)

Atlas Genet Cytogenet Oncol Haematol. 2009-10-01

Online version: http://atlasgeneticsoncology.org/gene/51160/spsb2-(spla-ryanodine-receptor-domain-and-socs-box-containing-2)